mounjaro tirzepatide news World Health Organization issues first-ever guidelines for use of GLP-1 weight loss medications Mounjaro® (tirzepatide) injection and Zepbound®

Management strategies may include lifestyle and dietary modifications, the use of over-the-counter antacids or prescription medications, and, in some cases, adjustments to the semaglutide regimen

Importantly, adherence remained high at 12 months (69%) and 18 months (61%)

June 27 : The FDA approved UCBs Rystiggo (rozanolixizumab), a subcutaneously administered humanized IgG4 monoclonal antibody, to treat generalized myasthenia gravis, a rare muscle-wasting autoimmune disease

The decision to invest in ReadyRx - GLP-1 should reflect commitment to comprehensive metabolic health improvement rather than quick weight loss

designed self-assembling peptide-based PROTAC nanoparticles (PT-NPs ) (Fig